|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 44, 198-211, January 2003
Copyright © 2003 by Lipid Research, Inc.


* Department of Biochemistry, Kirksville College of Osteopathic Medicine, Kirksville, MO
Departments of Ophthalmology, Pathology, and Anatomy, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL
1 To whom correspondence should be addressed. e-mail: rcenedella{at}kcom.edu
Simvastatin rapidly induced cataracts in young Chbb:Thom (CT) but not Sprague Dawley (SD) or Hilltop Wistar (HW) rats. Oral treatment for 14 but not 7 days committed CT rat lenses to cataract formation. The cholesterol to phospholipid molar ratio in lenses of treated CT rats was unchanged. Differences between strains in serum and ocular humor levels of simvastatin acid poorly correlated with susceptibility to cataracts. No significant differences were found between rat strains in the capacity of simvastatin acid to inhibit lens-basal sterol synthesis. Prolonged treatment with simvastatin comparably elevated HMG-CoA reductase protein and enzyme activity in lenses of both cataract resistant and sensitive strains. However, in contrast to SD and HW rats, where sterol synthesis was markedly increased, sterol synthesis in CT rat lenses remained at baseline. Discordant expression of sterol synthesis in CT rats may be due to inadequate upregulation of lens HMG-CoA synthase. HMG-CoA synthase protein levels, and to a much lesser extent mRNA levels, increased in lens cortex of SD but not CT rats.
Because upregulation of the sterol pathway may result in increased formation of isoprene-derived anti-inflammatory substances, failure to upregulate the pathway in CT rat lenses may reflect an attenuated compensatory response to injury that resulted in cataracts.
Abbreviations: CT, Chbb:Thom; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HMGR, 3-hydroxy-3-methylglutaryl CoA reductase; HMGS, 3-hydroxy-3-methylglutaryl CoA synthase; HW, Hilltop Wistar; SD, Sprague Dawley; SQS, squalene synthase
Supplementary key words 3-hydroxy-3-methylglutaryl CoA reductase 3-hydroxy-3-methylglutaryl CoA synthase sterol synthesis squalene synthase inflammation
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
R. J. Cenedella, R. Jacob, D. Borchman, D. Tang, A. R. Neely, A. Samadi, R. P. Mason, and P. Sexton Direct perturbation of lens membrane structure may contribute to cataracts caused by U18666A, an oxidosqualene cyclase inhibitor J. Lipid Res., July 1, 2004; 45(7): 1232 - 1241. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Mason, M. F. Walter, and R. F. Jacob Effects of HMG-CoA Reductase Inhibitors on Endothelial Function: Role of Microdomains and Oxidative Stress Circulation, June 1, 2004; 109(21_suppl_1): II-34 - II-41. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |